Medical Care Technologies Inc. (OTCID:MDCE) Reports Debt-Free Balance Sheet Alongside Continued StrainScan Pro Demos and Melanoma Scan Beta Review

Clean Balance-Sheet Milestone Reached While Melanoma Scan Beta, Wound Care Development, StrainScan Pro Demos and Subsidiary Operations Continue to Advance

MESA, AZ / ACCESS Newswire / September 24, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today announced that the Company is debt free as of September 23, 2026.

The Company views the milestone as a meaningful operating achievement. It reduces balance-sheet pressure at a time when MDCE is advancing multiple AI vision and software initiatives and continuing commercial activity through its wholly owned subsidiaries.

Medical Care Technologies is not pausing development because the cap table is cleaner. The opposite is the point. A debt-free position is intended to give the Company more flexibility to keep building.

What continues alongside the milestone

  • MDCE Melanoma Scan Beta – first human volunteer image datasets have been received and are in internal review for intake, body-map mapping, and change-over-time comparison. The platform remains in beta-stage development, has not received regulatory clearance, and is not intended to diagnose, treat, cure, or prevent any disease or medical condition.
  • MDCE Wound Care – the Company’s wound-monitoring application remains in development as a second health-imaging track.
  • StrainScan Pro – proprietary AI vision software for agricultural and foodservice quality applications continues through enterprise demonstration, including agricultural sessions and the first restaurant-service presentation path. Learn more at https://strainscanpro.com.
  • Infinite Auctions and Real Game Used – subsidiaries continue operating in premium memorabilia transactions and photo-match authentication, including the recently completed first Fanatics / Topps supply-and-authentication cycle.

“This is a clean-slate operating moment,” said Marshall Perkins, CEO of Medical Care Technologies. “As of September 23, 2026, Medical Care Technologies is debt free. That matters because we are still building. Melanoma Scan Beta is in volunteer-image review. Wound care development continues. StrainScan Pro is in live demonstration. Our subsidiaries are executing. We wanted investors to see the full picture: the Company is advancing its products and it is not doing that from under a stack of debt.”

This announcement states the Company’s debt status as of September 23, 2026. It does not constitute a projection of future profitability, cash position, revenue, or the absence of future financing needs. Results may vary. Medical Care Technologies is a technology company focused on software and AI vision solutions. StrainScan Pro is an enterprise visual analysis platform, not a medical device.

Investors and interested parties can learn more at:
https://www.medicalcaretechnologies.com
https://strainscanpro.com
https://infiniteauctions.com
https://realgameused.com

About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTCID:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. The Company also owns subsidiaries Infinite Auctions and Real Game Used. Visit: https://www.medicalcaretechnologies.com

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties, including development timelines, market conditions, capital resources, and operating results. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.

Contact Information:
Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: marshall@medicalcaretechnologies.com
Websites: https://www.medicalcaretechnologies.com | https://strainscanpro.com | https://infiniteauctions.com | https://realgameused.com

SOURCE: Medical Care Technologies Inc.

View the original press release on ACCESS Newswire

Staff

Recent Posts

As Microdosing Culture Grows, Sacred Connection Introduces Amazonian Grounding Botanicals to Solve Modern “Heady” Burnout

Addressing the growing demand for non-psychedelic micro-rituals, Sacred Connection bridges ancestral Amazonian preparations with North…

15 minutes ago

Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio

Launch introduces ondansetron 4 mg and 8 mg tablets for nausea and vomiting associated with…

15 minutes ago

Aptevo Advances Next-Generation Trispecific Candidate Toward Clinical Development

Company Making Critical Progress in Scalable Manufacturing and Preparing the Lead Trispecific Candidate for Future…

16 minutes ago

Tersis Technologies Hosts Private Climate Week Salon in New York

Invitation-only rooftop gathering during UNGA and Climate Week NYC convenes public-sector, institutional and industrial partners…

1 hour ago

Orange Insurance Services Commences Writing Policies and Exceeds Agency Growth Goals

Technology-Driven Florida Auto MGA Advances from Development to Active Operations as Distribution Network Continues to…

2 hours ago